Receptos' P2P Acquisition

Receptos raised a round of funding on July 14, 2015. Investors include Celgene.

Receptos (NASDAQ: RCPT) is a biopharmaceutical company focused on discovering, developing and commercializing innovative therapeutics in immune disease. The company's lead asset, RPC1063, is being dev…

Articles about Receptos' P2P Acquisition: